GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, AKR1C3, ALOX15, ALPL, APEX1, APP, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, NR3C1, PPARA, PTGS2, RORC, SLC6A3, SMAD3, SRC, TEK, TYR |
15.8107 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, AKR1C3, ALOX15, ALPL, APEX1, APP, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX1, EPHX2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, PPARA, PTGS2, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TYR |
14.9243 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, ALPL, APEX1, APP, AR, AXL, BCL2, CA9, CDK6, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, IGF1R, INSR, MMP2, MMP9, NR3C1, PPARA, PTGS2, RORC, SLC6A3, SRC, TEK, TYR |
14.4588 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, ALPL, APEX1, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX1, ESR1, ESRRA, FLT3, HSD11B2, NR3C1, PTGS2, RORC, SLC6A3, SRC, TEK, TYR |
14.4588 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH |
14.0844 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, AR, BCL2, CDC25B, CDK6, CSNK2A1, CXCL8, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NUAK1, PGR, PIM1, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH |
14.0167 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, EGFR, EPHX2, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, MIF, PPARA, PTGS1, PTGS2 |
13.5568 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, F3, FABP3, FABP4, FLT3, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, MIF, PPARA, PTGS1, PTGS2, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
13.3165 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
13.143 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
13.1206 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, MIF, PTGS1, PTGS2 |
12.0142 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, PTGS1, PTGS2 |
11.8766 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
11.768 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH |
11.768 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, MIF, PTGS1, PTGS2 |
11.7476 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP2, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH |
11.5938 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, APP, AR, BCL2, CA2, CA9, CSNK2A1, CXCL8, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, IGF1R, INSR, MMP2, NR3C1, PPARA, PTGS2, SMAD3, SRC, TEK |
11.5731 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH |
11.5042 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, ALPL, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CXCL8, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, NR3C1, PTGS2, RORC, SRC, TYR |
10.9121 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CYP1B1, DRD2, DRD4, EGFR, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, PTGS2, PTPN1, SRC, TEK, XDH |
10.8012 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APEX1, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, INSR, NR3C1, PPARA, PTGS2, SRC, TEK |
10.8012 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
10.6291 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP9, NUAK1, PTGS2, PTPN1, SRC, TEK, XDH |
10.483 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CSNK2A1, CXCL8, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESRRA, F3, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
10.4801 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH |
10.4801 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX1, EPHX2, FABP3, FUT7, GBA2, GLO1, HSPA1A, MIF, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH |
10.4642 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, ALOX15, ALPL, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX1, EPHX2, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NR3C1, NUAK1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR |
9.9271 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, ALOX15, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, PTGS2, SLC6A3, SRC |
9.7976 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, MIF, PTGS1, PTGS2 |
9.77413 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
9.60871 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AR, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESRRB, F3, FABP4, HSD11B2, HSD17B2, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TNKS2, TYR |
9.56588 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, ALPL, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD17B2, INSR, KDR, MET, MIF, MMP2, MMP9, PGR, PIM1, PPARA, PTGS2, RORC, SLC6A3, SMAD3, SRC, TEK, TNKS2, TOP2A, TYR |
9.40167 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.26679 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, PTGS1, PTGS2 |
9.26679 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AKR1C3, AR, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, DRD3, EGFR, ESR1, F3, FLT3, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PTGS2, TEK |
9.26679 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APEX1, APP, BCL2, CDK6, CXCL8, CYP19A1, CYP1B1, DRD2, DRD3, EGFR, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
9.21436 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, AKR1C3, ALOX15, ALPL, APEX1, APP, AR, AXL, BCL2, CDK6, CXCL8, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, PTGS2, RORC, SMAD3, SRC |
9.13016 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.13016 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APEX1, APP, BCL2, CDK6, CXCL8, CYP19A1, CYP1B1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
9.0645 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, ADRA2C, AKR1C3, ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH |
9.05788 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, ADRA2C, AKR1C3, ALOX15, APP, AR, AURKB, BCL2, CDC25B, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH |
8.8558 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, AKR1C3, ALOX15, ALPL, APEX1, APP, AR, AXL, BCL2, CDK6, CXCL8, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, NR3C1, PTGS2, RORC, SMAD3, SRC |
8.85442 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH |
8.80439 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APEX1, APP, BCL2, CXCL8, CYP19A1, CYP1B1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
8.75742 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH |
8.75111 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, MIF, PPARA, PTGS1, PTGS2 |
8.64378 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, EGFR, EPHX2, FABP3, FABP4, FUT7, GBA2, MET, MIF, PPARA, PTGS1, PTGS2 |
8.59495 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH |
8.49571 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.46315 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APEX1, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH |
8.43932 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APEX1, APP, BCL2, CDK6, CXCL8, CYP19A1, CYP1B1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
8.43825 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH |
8.34623 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A, XDH |
8.23176 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APEX1, APP, AR, AXL, BCL2, CA2, CA7, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
8.23176 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A, XDH |
8.19647 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
8.19044 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CXCL8, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.11078 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, GBA2, GLO1, MIF, PPARA, PTGS1, PTGS2 |
7.76014 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, ALOX15, AR, BCL2, CDK6, CXCL8, CYP19A1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, SLC6A3, SMAD3, SRC, TEK, XDH |
7.76014 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A, XDH |
7.64537 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PTGS1, PTGS2, TYR, XDH |
7.64537 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AR, AXL, BCL2, CA2, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR |
7.64537 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, AKR1C3, ALOX15, ALPL, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CDK6, CXCL8, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP2, MMP9, NR3C1, NUAK1, PTGS2, PTPN1, RORC, SMAD3, SRC, TOP2A |
7.64537 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD2, DRD3, DRD4, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.64537 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, INSR, KDR, MMP9, PGR, PIM1, PPARA, PTGS2, RORC, SLC6A3, SMAD3, SRC, TEK, TYR |
7.6003 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD2, DRD3, DRD4, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.57086 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD2, DRD4, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MIF, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.54452 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD2, DRD4, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MIF, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.54452 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, FABP3, HSD11B2, KDR, NR3C1, PTGS2, SLC6A2, SLC6A3, SRC |
7.53345 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, DRD2, DRD4, EGFR, FLT3, INSR, KDR, MIF, PTPN1, SRC, TEK, XDH |
7.39705 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
7.19637 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DRD2, DRD3, DRD4, EGFR, EPHX2, HSPA1A, SLC6A3 |
7.18852 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
7.12919 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK |
7.12288 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2 |
7.00802 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ADRA2C, AR, BCL2, CXCL8, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, XDH |
7.00802 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, EPHX1, EPHX2, KDR, SLC6A3, SRC |
6.99589 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, ADRA2C, AR, BCL2, CXCL8, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, XDH |
6.98923 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, BCL2, CA2, CA7, CDK6, DRD2, DRD3, EGFR, KDR, MIF, PTGS2, SRC, TNKS, TNKS2 |
6.96558 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, PGR, PIM1, PPARA, RORC, SRC |
6.95626 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD2, DRD4, EGFR, ESRRB, FLT3, INSR, KDR, MIF, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
6.93878 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, DRD2, DRD4, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, MIF, PTPN1, SRC, TEK, XDH |
6.91834 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, PGR, PPARA, RORC, SRC, TOP2A |
6.88554 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, GBA2, SLC6A3, TYR |
6.85144 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, ALPL, APEX1, APP, AR, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, NR3C1, PTGS2, RORC, SRC |
6.80309 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.73405 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.61989 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APEX1, APP, AR, AXL, CDK6, CXCL8, CYP1B1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, NR3C1, PTGS2, RORC, SRC |
6.59981 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.58292 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, DRD2, DRD3, DRD4, EGFR, FABP3, FLT3, HSD11B2, IGF1R, INSR, MMP2, PPARA, PTGS2, SLC6A3, SRC, TEK, TYR |
6.54338 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD2, DRD4, EGFR, FLT3, INSR, KDR, MIF, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
6.54338 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK |
6.5223 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, APP, BCL2, CXCL8, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.51158 |
[BP] GO:0008217 |
None
|
ADORA1, AR, DRD2, DRD3, EPHX2, HSD11B2, PPARA, PTGS1, PTGS2, SMAD3 |
6.49439 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1C3, ALOX15, APEX1, APP, AR, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH |
6.42422 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD2, DRD4, DUSP3, EGFR, ESRRB, FABP4, FLT3, IGF1R, INSR, KDR, MIF, MMP9, PPARA, PTGS2, PTPN1, SRC, TEK, XDH |
6.39559 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9, PTGS2, SLC6A3 |
6.34984 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, APP, BCL2, CXCL8, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.3316 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, ADRA2C, APP, AR, AXL, BCL2, CA2, CXCL8, CYP1B1, DRD2, DRD3, EGFR, ESRRB, F3, HSPA1A, KDR, MET, MIF, MMP12, MMP9, PIM1, PTGS2, SLC6A3, SMAD3, SRC, TEK |
6.23383 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
6.23383 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1C3, ALOX15, APEX1, APP, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH |
6.22612 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, DRD2, DRD3, EGFR, F3, INSR, MET, SRC, TEK, XDH |
6.21473 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, MIF, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
6.21353 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, APP, BCL2, CXCL8, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.19512 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, DRD2, DRD3, DRD4, EGFR, FABP3, FLT3, HSD11B2, IGF1R, INSR, MMP2, PPARA, PTGS2, SLC6A3, SRC, TEK, TYR |
6.07035 |
[BP] GO:0048545 |
response to steroid hormone
|
AKR1C3, ALPL, AR, BCL2, CA2, EGFR, FLT3, HSD11B2, NR3C1, PTGS2, SRC |
6.05919 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, CXCL8, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, MIF, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
6.03223 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, APEX1, APP, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, PTGS1, PTGS2, SRC |
6.01835 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, APP, CDK6, CYP19A1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, MET, MIF, MMP12, MMP2, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.01082 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, APP, BCL2, CXCL8, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.01082 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, AKR1C3, APEX1, APP, AR, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TNKS, TNKS2, XDH |
5.97038 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, DUSP3, EGFR, EPHX2, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, PTPN1, SRC, TEK, TNKS, XDH |
5.97038 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, MET, SMAD3, SRC |
5.94483 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MIF, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
5.83715 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, CSNK2A1, DRD2, DRD4, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, KDR, MIF, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.812 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, GBA2, GLO1, MIF, PIM1, PPARA, PTGS1, PTGS2, TYR |
5.79745 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, APP, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CXCL8, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, MIF, PIM1, PTGS2, SMAD3, SRC, TNKS, TOP2A |
5.7931 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS |
5.7931 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, AKR1C3, CYP1A1, DRD3, EPHX2, FABP3, FLT3, PPARA, PTGS2, RORC, SRC, TEK |
5.77167 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.7401 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, AKR1C3, APEX1, APP, AR, CXCL8, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, NR3C1, PTGS2, SMAD3, SRC |
5.73952 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.69312 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AR, AXL, BCL2, CA2, CDK6, CXCL8, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PIM1, PTGS2, SLC6A3, SMAD3, SRC, TEK, TNKS2, XDH |
5.68502 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CXCL8, CYP19A1, DRD2, DRD3, EGFR, ESR1, F3, FABP4, KDR, MET, MIF, MMP12, PPARA, PTGS2, SLC6A3, SMAD3, TEK |
5.6712 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD2, DRD4, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, KDR, MIF, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.6712 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APEX1, APP, AR, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH |
5.64026 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, BCL2, DRD2, DRD3, DRD4, GPR35, MMP9, PTGS2 |
5.61169 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1C3, ALOX15, APEX1, APP, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH |
5.59746 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, DUSP3, EGFR, EPHX2, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, PTPN1, SRC, TEK, TNKS, XDH |
5.58672 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APP, AR, AXL, BCL2, CA1, CA2, CDK6, CSNK2A1, CXCL8, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MIF, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TNKS, TNKS2 |
5.55931 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
5.50101 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD2, DRD3, DRD4, EGFR, INSR, PTGS2, SLC6A2, SLC6A3, SMAD3 |
5.47011 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
5.40342 |
[BP] GO:0022414 |
reproductive process
|
ADRA2C, AKR1B1, AKR1C3, ALPL, APP, AR, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD11B2, HSD17B2, INSR, MMP2, MMP9, PGR, PTGS2, SRC, TOP2A |
5.35158 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA9, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD4, EGFR, EPHX2, HSD11B2, HSPA1A, MIF, MMP2, MMP9, NUAK1, PPARA, PTGS1, PTGS2, PTPN1, SLC6A2, SMAD3, SRC, TEK, TOP2A |
5.34852 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
5.33461 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
5.33461 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
5.33461 |
[BP] GO:0031960 |
response to corticosteroid
|
AKR1C3, ALPL, BCL2, EGFR, FLT3, HSD11B2, NR3C1, PTGS2, SRC |
5.28647 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
5.28647 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, ADRA2C, APP, AR, AURKB, BCL2, CDC25B, DRD2, DRD4, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, INSR, MET, MIF, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
5.23319 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, APP, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3 |
5.21764 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, APP, AURKB, BCL2, CDC25B, CDK6, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TNKS, TOP2A |
5.20359 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, GBA2, GLO1, MIF, PIM1, PPARA, PTGS1, PTGS2, TYR |
5.19626 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APEX1, APP, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH |
5.18357 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, EPHX1, EPHX2, PTGS1, RORC |
5.17359 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, BCL2, DRD2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
5.13735 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PTGS2, PTPN1, SRC, TEK, XDH |
5.12607 |
[BP] GO:0006082 |
organic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, GBA2, GLO1, MIF, PIM1, PPARA, PTGS1, PTGS2, TYR |
5.08976 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD2, DRD3, DRD4, SLC6A3, TYR |
5.07521 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, AR, BCL2, CXCL8, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, XDH |
5.06571 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD2, DRD4, EGFR, PTGS2 |
4.99299 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AKR1C3, ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, PGR, PTGS2, SRC |
4.96681 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, MMP12, NR3C1, PGR, PPARA, PTGS2, RORC, SMAD3, SRC, TNKS, TNKS2, TOP2A |
4.96033 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
4.95488 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AKR1C3, ALPL, APP, AR, AXL, BCL2, CBR1, CDC25B, CDK6, CYP1A1, DRD2, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, KDR, MET, MIF, MMP2, MMP9, PGR, PTGS2, RORC, SMAD3, SRC, TEK, TOP2A |
4.95159 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DRD3, DUSP3, ESR1, HSPA1A, IGF1R, MET, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
4.95159 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD2, DRD4, EGFR, FLT3, INSR, KDR, MIF, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
4.94176 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, APEX1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
4.9134 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GBA2, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH |
4.90006 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, AKR1C3, APEX1, APP, AR, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, NR3C1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TNKS, TNKS2, XDH |
4.89404 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD2, DRD3, EGFR, HSD11B2, HSPA1A, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TYR |
4.86726 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EPHX1, EPHX2, FABP3, FABP4, FUT7, GBA2, HSPA1A, MMP1, MMP12, MMP2, MMP9, SLC6A3, SRC, XDH |
4.86638 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, MIF, SRC |
4.84257 |
[BP] GO:0019371 |
None
|
AKR1C3, CBR1, PTGS1, PTGS2 |
4.83524 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, EGFR, PPARA, SMAD3 |
4.83002 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, ADRA2C, APP, AURKB, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MIF, PTPN1, SRC, TEK, TNKS |
4.80233 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, MMP12, NR3C1, PGR, PPARA, PTPN1, RORC, SMAD3, SRC, TNKS, TNKS2, TOP2A |
4.80178 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, AKR1C3, CSNK2A1, DRD2, DRD3, DRD4, SLC6A3 |
4.77688 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AXL, BCL2, CA2, CA7, CYP19A1, DRD2, DRD3, DRD4, EGFR, GPR35, HSPA1A, INSR, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC |
4.7758 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.70271 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.64777 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MIF, PTGS1, PTGS2 |
4.64206 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TNKS |
4.64075 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRA2C, APP, AR, AXL, BCL2, CA2, CDK6, CXCL8, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F3, INSR, KDR, MIF, NUAK1, PIM1, PPARA, PTGS2, RORC, SLC6A3, SMAD3, SRC, TEK, TNKS2, XDH |
4.62728 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
4.55971 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MIF, MMP9, PTGS2, PTPN1, SRC |
4.5596 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MET, MMP12, NR3C1, PGR, PPARA, PTGS2, RORC, SMAD3, SRC, TNKS, TNKS2, TOP2A |
4.55384 |
[BP] GO:0045744 |
None
|
ADRA2A, CXCL8, DRD2, DRD3, MET |
4.54727 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, ADRA2C, APP, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MIF, PTPN1, SRC, TEK |
4.5438 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, TNKS, TNKS2, TOP2A |
4.51145 |
[BP] GO:0032845 |
None
|
ADORA1, ADRA2A, BCL2, DRD2, MIF, SRC, TNKS, TNKS2 |
4.49166 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, DRD4, PPARA, RORC, TOP2A |
4.48315 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, BCL2, CA2, CYP19A1, DRD2, DRD3, DRD4, EGFR, INSR, MIF, MMP12, PTGS2, SMAD3, SRC |
4.48315 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, ADRA2C, APP, AURKB, BCL2, CDC25B, DRD2, DRD4, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, MIF, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
4.47644 |
[BP] GO:0051172 |
None
|
ADRA2A, APEX1, APP, AR, AURKB, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MIF, MMP12, MMP9, NR3C1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TNKS, TNKS2, XDH |
4.46014 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.44745 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
4.41202 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, DRD4, DUSP3, EGFR, FLT3, IGF1R, INSR, MIF, PTPN1, SRC |
4.3655 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA |
4.35221 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, EGFR, F3, INSR, MET, SRC, TEK |
4.32922 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, ADRA2C, AURKB, CDC25B, DRD2, DRD4, EGFR, FLT3, INSR, MIF, PTPN1, SRC, TEK, TNKS |
4.32103 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, DUSP3, EGFR, KDR, MIF, PTPN1, SRC, TEK |
4.3096 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
ADRA2A, BCL2, DRD2, DRD4, GPR35, PTGS2 |
4.30788 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, ADRA2C, APP, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MIF, PTPN1, SRC |
4.27617 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, EPHX2, PTGS2, SRC, TEK |
4.27376 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, HSD11B2, IGF1R, INSR, PPARA, PTGS2, SRC, TEK |
4.26816 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, DRD3, SLC6A3, TNKS2 |
4.23621 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPR35, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH |
4.22912 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CDK6, CYP1B1, EGFR, KDR, NR3C1, PTGS2, SRC |
4.20824 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, MIF, PTGS1, PTGS2 |
4.19252 |
[BP] GO:0071396 |
cellular response to lipid
|
AKR1C3, AR, AXL, CDK6, CXCL8, EGFR, ESR1, FLT3, NR3C1, RORC, SRC |
4.19222 |
[BP] GO:0032225 |
None
|
DRD2, DRD3, DRD4, PTGS2 |
4.18692 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, DRD3, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
4.14205 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, APP, CA2, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, PTGS2, PTPN1, SMAD3, SRC |
4.12959 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APEX1, APP, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, INSR, MIF, TNKS |
4.08396 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
4.08052 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD2, DRD3, EGFR, PTGS2, TNKS, TNKS2 |
4.06816 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
AKR1C3, BCL2, CYP1B1, EGFR, INSR, PTGS2, SMAD3, XDH |
4.01404 |
[BP] GO:0071383 |
None
|
AKR1C3, AR, EGFR, FLT3, NR3C1, SRC |
4.00158 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, ADRA2C, APP, EGFR, FLT3, MIF, PTPN1, SRC |
3.99435 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3, GBA2 |
3.98164 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, DRD2, DRD3, DRD4, EGFR, PTGS2 |
3.97747 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, DRD2, DRD3, DRD4, EGFR, PTGS2 |
3.97747 |
[BP] GO:0032413 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.97543 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.96833 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, ADRA2C, CDC25B, DRD2, DRD4, EGFR, FLT3, INSR, MIF, PTPN1, SRC, TEK |
3.96135 |
[BP] GO:0051952 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD2, DRD3, DRD4 |
3.94631 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
3.89376 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
3.89376 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, NR3C1, PGR, SRC |
3.8861 |
[BP] GO:0040008 |
regulation of growth
|
APP, AR, BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR2, HSPA1A, INSR, PIM1, SLC6A3, SMAD3, TNKS2 |
3.87082 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, MET, MIF, PIM1, SRC, TEK, TYR |
3.86466 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, CSNK2A1, DRD2, DRD4, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.83439 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.82421 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, FABP3, GPR35, SMAD3 |
3.75933 |
[BP] GO:0032410 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.74608 |
[BP] GO:1904063 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.74608 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.72005 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH |
3.6948 |
[BP] GO:0042058 |
None
|
ADORA1, ADRA2A, ADRA2C, APP, EGFR, MMP9 |
3.66039 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, ADRA2A, ADRA2C, APP, BCL2, DRD2, DRD3, DRD4, GPR35, HSPA1A, MMP9, PTGS2 |
3.66039 |
[BP] GO:0050678 |
None
|
AR, CDK6, EGFR, F3, KDR, MMP12, PGR, SMAD3, TEK, XDH |
3.66039 |
[BP] GO:0051254 |
None
|
APP, AR, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, TNKS, TOP2A |
3.66039 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, MMP12, MMP2, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
3.64957 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, CXCL8, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MIF, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.64461 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
3.63943 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.60897 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.60897 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD2 |
3.58197 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, EGFR, KDR, MIF, SRC, TEK |
3.57706 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, DRD4, EGFR, FLT3, INSR, MIF, PTPN1, SRC |
3.57623 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, NR3C1, PTGS2 |
3.57038 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
AKR1C3, EGFR, INSR, PTGS2, SMAD3, XDH |
3.56421 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, BCL2, CDK6, CXCL8, CYP1B1, DRD2, FABP3, HSPA1A, PTGS2, SMAD3, XDH |
3.54068 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ADRA2C, APP, AR, AXL, BCL2, CA2, CXCL8, CYP1B1, DRD2, ESRRB, F3, INSR, KDR, PIM1, PTGS2, SLC6A3, SMAD3, SRC, TEK |
3.53689 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
ADRA2A, AKR1C3, APEX1, AR, EGFR, ESR1, FLT3, INSR, NR3C1, SRC |
3.53148 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, ADRA2C, APP, AR, BCL2, CSNK2A1, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, PTGS2, PTPN1, SMAD3, SRC |
3.53004 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, ADRA2C, CDC25B, DRD2, DRD4, EGFR, FLT3, INSR, MIF, PTPN1, SRC |
3.52547 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.52005 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, GPR35, MIF, MMP9, PTGS2 |
3.52005 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, INSR, SRC |
3.51429 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
3.51429 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TNKS |
3.49598 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, APP, CDC25B, CYP1A1, DRD3, DUSP3, INSR |
3.48752 |
[BP] GO:0034766 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.47392 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, EPHX2, PTGS2, SRC, TEK |
3.47392 |
[BP] GO:0050927 |
None
|
CXCL8, F3, KDR, SMAD3 |
3.45769 |
[BP] GO:0070201 |
None
|
ACHE, ADRA2A, ADRA2C, APP, BCL2, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, PTGS2, PTPN1, SMAD3, SRC |
3.4492 |
[BP] GO:0045893 |
None
|
APP, AR, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, TNKS, TOP2A |
3.4492 |
[BP] GO:1903508 |
None
|
APP, AR, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, TNKS, TOP2A |
3.4492 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.4492 |
[BP] GO:0051940 |
None
|
DRD2, DRD3, DRD4 |
3.4492 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.4492 |
[BP] GO:0051584 |
None
|
DRD2, DRD3, DRD4 |
3.4492 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.4492 |
[BP] GO:1902680 |
None
|
APP, AR, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, TNKS, TOP2A |
3.44853 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD2, DRD3, KDR, SRC |
3.44539 |
[BP] GO:0003014 |
None
|
ADORA1, AKR1B1, AKR1C3, BCL2, DRD2, HSD11B2 |
3.44043 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD2, DRD3, MIF, PPARA, SLC6A3, SMAD3, TEK |
3.42785 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CXCL8, EGFR, F3, FABP4, KDR, MET, MIF, PTGS2, SMAD3 |
3.42785 |
[BP] GO:0050926 |
None
|
CXCL8, F3, KDR, SMAD3 |
3.41258 |
[BP] GO:0006693 |
None
|
AKR1C3, MIF, PTGS1, PTGS2 |
3.41258 |
[BP] GO:0006692 |
None
|
AKR1C3, MIF, PTGS1, PTGS2 |
3.41258 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, HSPA1A, MIF, MMP9, PTGS2, PTPN1, SRC |
3.41034 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.39694 |
[BP] GO:0045934 |
None
|
ADRA2A, APEX1, AR, AURKB, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR3C1, PPARA, RORC, SMAD3, SRC, TNKS, TNKS2 |
3.38097 |
[BP] GO:1901184 |
None
|
ADORA1, ADRA2A, ADRA2C, APP, EGFR, MMP9 |
3.37618 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, APEX1, APP, AR, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, NR3C1, NR3C2, PGR, PPARA, PTGS2, RORC, SLC6A3, SMAD3, TOP2A, TYR, XDH |
3.35748 |
[BP] GO:0034763 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.35351 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APEX1, APP, AR, AURKB, CSNK2A1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, KDR, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TNKS, TNKS2, XDH |
3.33213 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, SRC |
3.33014 |
[BP] GO:0001775 |
cell activation
|
ADRA2A, ADRA2C, ALOX5, APP, AXL, BCL2, CXCL8, EGFR, FLT3, FUT7, HSPA1A, MIF, MMP9, RORC, SMAD3, SRC |
3.32811 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA |
3.32054 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, GPR35, SMAD3 |
3.3165 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, EPHX2 |
3.31152 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.30606 |
[BP] GO:0042417 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.29974 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, KDR, SMAD3, SRC, TEK |
3.29339 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.27811 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MIF, MMP9, PTGS2, PTPN1, SRC |
3.27811 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX15, MIF, PTGS1, PTGS2 |
3.24556 |
[BP] GO:0007176 |
None
|
ADORA1, ADRA2A, ADRA2C, APP |
3.24556 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, EGFR |
3.208 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, CSNK2A1, DRD2, DRD4, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.20112 |
[BP] GO:0022898 |
None
|
ADRA2A, APP, BCL2, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.19731 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
3.19108 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.18967 |
[BP] GO:0007195 |
None
|
DRD2, DRD3, DRD4 |
3.17362 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.17362 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A |
3.16538 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, MMP9 |
3.14185 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2, SLC6A3 |
3.14185 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
ADRA2C, APP, AR, AXL, BCL2, CA2, CDK6, CXCL8, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, F3, INSR, KDR, PIM1, PTGS2, SMAD3, SRC, TEK, XDH |
3.14185 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
3.12362 |
[BP] GO:0051223 |
None
|
ACHE, ADRA2A, ADRA2C, APP, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, PTGS2, PTPN1, SMAD3, SRC |
3.10306 |
[BP] GO:0048638 |
regulation of developmental growth
|
APP, AR, BCL2, DRD2, DRD3, INSR, PIM1, SLC6A3, TNKS2 |
3.10235 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, FUT7, GBA2, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH |
3.09719 |
[BP] GO:0007194 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
3.09475 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.09475 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADORA3, ADRA2A, AKR1C3, APEX1, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NR3C1, NR3C2, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TNKS, TNKS2, TOP2A |
3.09475 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK |
3.08432 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
3.07969 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, ADRA2A, ADRA2C, DRD2, DRD4, EGFR, INSR, PTPN1, SRC |
3.07857 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APP, BCL2, CYP1B1, DRD2, DRD3, EGFR, EPHX2, HSD11B2, INSR, PTGS2, SLC6A3, SRC, TEK, TYR |
3.06003 |
[BP] GO:0034776 |
None
|
DRD2, DRD3, DRD4 |
3.0585 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.0585 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, ADRA2C, FLT3, MIF, PTPN1, SRC |
3.0585 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.04989 |
[BP] GO:0048732 |
gland development
|
AR, BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
3.04164 |
[BP] GO:0032409 |
None
|
ADRA2A, APP, BCL2, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.04164 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, GLO1 |
3.02732 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, APP, AXL, BCL2, CA2, CDK6, CXCL8, CYP19A1, DRD2, DUSP3, ESR1, ESRRA, HSPA1A, MIF, MMP12, MMP2, PTPN1, SMAD3, SRC |
3.0215 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, CXCL8, EGFR, INSR, KDR, NR3C1, SMAD3, SRC |
3.00723 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC |
3.00723 |
[BP] GO:0032148 |
None
|
ADRA2A, ADRA2C, INSR, SRC |
3.00723 |
[BP] GO:0031280 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
3.00723 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, EGFR, NR3C1, SRC |
2.99085 |
[BP] GO:1900543 |
None
|
ADRA2A, DRD2, DRD3, DRD4, PPARA |
2.97554 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DRD4, DUSP3, EGFR, FLT3, IGF1R, INSR, MIF, PTPN1, SRC |
2.96379 |
[BP] GO:0045741 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.95357 |
[BP] GO:0045980 |
None
|
ADRA2A, DRD2, DRD3, DRD4, PPARA |
2.95138 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
2.94851 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
2.94851 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
2.94851 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.94851 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
2.94851 |
[BP] GO:0050920 |
regulation of chemotaxis
|
CXCL8, CYP19A1, F3, KDR, MET, MIF, SMAD3 |
2.94711 |
[BP] GO:0010628 |
positive regulation of gene expression
|
APP, AR, DRD2, DRD3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, SRC, TNKS, TOP2A |
2.92926 |
[BP] GO:0051350 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.92926 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC, TEK |
2.92831 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, GPR35, SMAD3 |
2.92634 |
[BP] GO:0031326 |
regulation of cellular biosynthetic process
|
ADORA3, ADRA2A, AKR1C3, APEX1, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HSPA1A, IGF1R, INSR, MET, MMP12, NR3C1, NR3C2, PGR, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TNKS, TNKS2, TOP2A |
2.91362 |
[BP] GO:0061097 |
None
|
ADORA1, ADRA2A, ADRA2C, APP, PTPN1 |
2.91362 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, EPHX2, PTGS2 |
2.91362 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, EPHX2, PTGS2 |
2.91362 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.89697 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.89697 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.89259 |
[BP] GO:0045742 |
None
|
ADORA1, ADRA2A, ADRA2C, MMP9 |
2.89259 |
[BP] GO:0050708 |
None
|
ACHE, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, SRC |
2.88395 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, CDK6, KDR, SMAD3, SRC, TEK |
2.87593 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.87593 |
[BP] GO:0060134 |
None
|
DRD2, DRD3, SLC6A3 |
2.87593 |
[BP] GO:0033604 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.87593 |
[BP] GO:0001516 |
None
|
MIF, PTGS1, PTGS2 |
2.87593 |
[BP] GO:0046457 |
None
|
MIF, PTGS1, PTGS2 |
2.87593 |
[BP] GO:0007193 |
None
|
ADORA1, ADRA2A, DRD2, DRD3, DRD4 |
2.87271 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
2.87271 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SMAD3, SRC, TNKS |
2.83658 |
[BP] GO:0009991 |
response to extracellular stimulus
|
AKR1C3, ALPL, AXL, BCL2, CYP1A1, EGFR, HSD11B2, PTGS2, SRC, TYR |
2.82509 |
[BP] GO:0046683 |
response to organophosphorus
|
APEX1, APP, PTGS2, SLC6A3, TEK, TYR |
2.81555 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, MIF |
2.81555 |
[BP] GO:1901186 |
None
|
ADORA1, ADRA2A, ADRA2C, MMP9 |
2.81555 |
[BP] GO:1901020 |
None
|
ADRA2A, DRD2, DRD4, GPR35 |
2.81555 |
[BP] GO:0055080 |
cation homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, GPR35, SMAD3 |
2.81422 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.78455 |
[BP] GO:0051580 |
None
|
DRD2, DRD3, DRD4 |
2.78455 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, EPHX2, PTGS2 |
2.78455 |
[BP] GO:1901570 |
None
|
ALOX15, ALOX5, MIF, PTGS1, PTGS2 |
2.77561 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DRD4, EGFR, FLT3, INSR, MIF, PTPN1, SRC |
2.77033 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, EPHX2, PTGS2 |
2.77003 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, EGFR, NR3C1, SRC |
2.75343 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.74102 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.74102 |
[BP] GO:0048729 |
tissue morphogenesis
|
AR, BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.73884 |
[BP] GO:0045944 |
None
|
APP, AR, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, MET, MMP12, NR3C1, PGR, PPARA, SMAD3, TNKS, TOP2A |
2.73743 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, PTGS2, TYR |
2.73445 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APEX1, APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, INSR |
2.73076 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.7058 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, CDK6, DUSP3, EGFR, HSPA1A, IGF1R, MET, MIF, NUAK1, PTGS2, PTPN1, XDH |
2.69512 |
[BP] GO:0043434 |
None
|
APEX1, FABP3, HSD11B2, INSR, PPARA, PTGS2, SRC, TEK |
2.69031 |
[BP] GO:0070848 |
response to growth factor
|
APP, CXCL8, EGFR, INSR, KDR, NR3C1, SMAD3, SRC |
2.68024 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, MIF |
2.67248 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.67248 |
[BP] GO:1903170 |
None
|
ADRA2A, DRD2, DRD4, GPR35 |
2.67248 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.67248 |
[BP] GO:0061098 |
None
|
ADORA1, ADRA2A, ADRA2C, PTPN1 |
2.67248 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.6611 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK, TNKS, TOP2A |
2.65513 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.64893 |
[BP] GO:0030818 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.63634 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.63095 |
[BP] GO:0045986 |
None
|
ADORA1, ADRA2C, PTGS2 |
2.63095 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.63095 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD2, DRD3, EGFR, PTGS2, TYR |
2.62815 |
[BP] GO:0051704 |
multi-organism process
|
ADRA2C, APP, AXL, BCL2, CDK6, CYP1A1, DRD3, DRD4, EGFR, HSD11B2, HSPA1A, INSR, KDR, MET, MMP1, MMP12, SMAD3, SRC |
2.61428 |
[BP] GO:0045761 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.60752 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
CDK6, KDR, SMAD3, TEK |
2.60752 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, AKR1C3, ALOX15, APEX1, AXL, BCL2, CA2, CA9, CXCL8, CYP1B1, EGFR, HSPA1A, MIF, MMP9, NUAK1, PTGS2, PTPN1, SRC, TOP2A |
2.59112 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, BCL2, CDK6, CXCL8, CYP1B1, DUSP3, KDR, NUAK1, PPARA, SMAD3, SRC, TEK |
2.59056 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AXL, BCL2, CXCL8, CYP1B1, DRD2, DRD3, EGFR, IGF1R, INSR, KDR, MET, MIF, NUAK1, PTPN1, SRC, TEK |
2.58909 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
2.58579 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
2.58254 |
[BP] GO:0014074 |
response to purine-containing compound
|
APEX1, APP, PTGS2, SLC6A3, TEK, TYR |
2.58254 |
[BP] GO:0009410 |
None
|
DRD2, DRD3, DRD4, EGFR, NR3C1, SLC6A3 |
2.58254 |
[BP] GO:0030803 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.57673 |
[BP] GO:1901386 |
None
|
DRD2, DRD4, GPR35 |
2.56487 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.56487 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EPHX1, EPHX2, FABP3, FABP4, GBA2, HSPA1A, SLC6A3, SRC, XDH |
2.56487 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.56487 |
[BP] GO:1900673 |
olefin metabolic process
|
CYP1A1, EPHX2 |
2.56487 |
[BP] GO:0051944 |
None
|
DRD2, DRD4 |
2.56487 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.56487 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.56487 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.56487 |
[BP] GO:0051586 |
None
|
DRD2, DRD4 |
2.56487 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.56487 |
[BP] GO:0006357 |
None
|
APP, AR, AURKB, CA9, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, GLO1, HSPA1A, MET, MMP12, NR3C1, PGR, PPARA, RORC, SMAD3, TNKS, TOP2A |
2.55856 |
[BP] GO:0050433 |
None
|
ADRA2A, ADRA2C, DRD2, DRD3 |
2.55539 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH |
2.55469 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
2.55442 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
AR, BCL2, HSPA1A, MIF, MMP9, PTGS2, PTPN1, SMAD3, SRC |
2.55442 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, MIF, MMP12, SRC |
2.54654 |
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, MIF |
2.54549 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, ADRA2A, ADRA2C, CYP19A1, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, SRC |
2.53699 |
[BP] GO:0030815 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.52595 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EPHX2, FABP3, FABP4, FUT7, GBA2, HSPA1A, SLC6A3, XDH |
2.51566 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
2.51484 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRA2A, APEX1, BCL2, CSNK2A1, EGFR, ESRRB, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3 |
2.50784 |
[BP] GO:0032412 |
None
|
ADRA2A, APP, DRD2, DRD3, DRD4, GPR35, MMP9 |
2.50318 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, PPARA, PTGS2, SMAD3, TEK |
2.50318 |
[BP] GO:1900372 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.49805 |
[BP] GO:0030809 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.49805 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CXCL8, CYP1B1, F3, KDR, PTGS2, TEK |
2.48577 |
[BP] GO:0051591 |
None
|
APEX1, APP, SLC6A3, TEK, TYR |
2.47115 |
[BP] GO:0010906 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.47115 |
[BP] GO:0030800 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.46738 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
2.46738 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD2, DRD3, DRD4 |
2.45974 |
[BP] GO:0016101 |
None
|
AKR1B10, AKR1C3, CYP1A1, CYP1B1, EGFR |
2.45469 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, EGFR, IGF1R, INSR, MMP2, PTGS2, SRC |
2.45469 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
ADRA2A, CYP1B1, DRD2, HSPA1A, MIF, MMP12, PTGS2, SMAD3, SRC |
2.45469 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.45077 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.45077 |
[BP] GO:0019219 |
regulation of nucleobase-containing compound metabolic process
|
ADORA3, ADRA2A, APEX1, APP, AR, AURKB, CA9, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, HSPA1A, IGF1R, INSR, MET, MMP12, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TNKS, TNKS2, TOP2A |
2.44543 |
[BP] GO:2001258 |
None
|
DRD2, DRD4, GPR35, MMP9 |
2.44091 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
2.43375 |
[BP] GO:0040013 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, MIF |
2.42893 |
[BP] GO:0033138 |
positive regulation of peptidyl-serine phosphorylation
|
APP, BCL2, EGFR, MIF, PTGS2 |
2.41905 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CYP1A1, MIF, PTGS2, SLC6A3 |
2.4141 |
[BP] GO:0032989 |
cellular component morphogenesis
|
APP, AR, AXL, BCL2, DRD2, EGFR, MET, SRC, TEK |
2.4141 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.4141 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.4141 |
[BP] GO:0000904 |
cell morphogenesis involved in differentiation
|
AR, AXL, MET, SRC, TEK |
2.40315 |
[BP] GO:0048148 |
None
|
DRD2, DRD3, DRD4 |
2.39287 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.39287 |
[BP] GO:0071880 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.39287 |
[BP] GO:0031667 |
response to nutrient levels
|
AKR1C3, ALPL, BCL2, CYP1A1, EGFR, HSD11B2, PTGS2, SRC, TYR |
2.39252 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.39252 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.39252 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.39252 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.39252 |
[BP] GO:0048146 |
positive regulation of fibroblast proliferation
|
CDK6, EGFR, ESR1, MIF |
2.39252 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.39252 |
[BP] GO:0015909 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.39252 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, AKR1C3, ALOX15, CYP19A1, SLC6A3, TYR |
2.39252 |
[BP] GO:1900542 |
None
|
ADRA2A, DRD2, DRD3, DRD4, ESRRB, INSR, PPARA |
2.39252 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, ALOX15, AXL, CDK6, CYP19A1, DRD2, DUSP3, MIF, MMP12 |
2.38561 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA2A, ADRA2C, CXCL8, DRD2, DRD3, EGFR, KDR |
2.38255 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.37186 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.36456 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.36456 |
[BP] GO:0016477 |
cell migration
|
AXL, CXCL8, CYP1B1, DRD2, EGFR, FUT7, KDR, MIF, MMP1, MMP12, MMP9, SRC, TEK |
2.35086 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.34218 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.34218 |
[BP] GO:0031623 |
None
|
ACHE, CXCL8, DRD2, DRD3 |
2.33789 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.33789 |
[BP] GO:0006140 |
None
|
ADRA2A, DRD2, DRD3, DRD4, ESRRB, INSR, PPARA |
2.32862 |
[BP] GO:0035625 |
None
|
ADRA2A, ADRA2C |
2.32862 |
[BP] GO:0032811 |
None
|
ADRA2A, ADRA2C |
2.32862 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.32862 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.32862 |
[BP] GO:0097176 |
epoxide metabolic process
|
EPHX1, EPHX2 |
2.32862 |
[BP] GO:0051582 |
None
|
DRD2, DRD4 |
2.32862 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.32862 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, BCL2, DRD2, EGFR, MIF, MMP12, PTGS2, SMAD3, SRC |
2.31893 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, MMP9 |
2.31779 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH |
2.31584 |
[BP] GO:0098657 |
import into cell
|
ACHE, ADORA1, ALOX15, APP, AXL, CXCL8, DRD2, DRD3, SLC6A2, SLC6A3 |
2.31574 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.31574 |
[BP] GO:0010811 |
positive regulation of cell-substrate adhesion
|
ALOX15, CDK6, KDR, SMAD3, TEK |
2.31574 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, CYP19A1, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, SRC |
2.29796 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA2A, ADRA2C, DRD2, DRD3, EGFR, GPR35, PTGS2, SMAD3 |
2.29796 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.29796 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.2951 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.2951 |
[BP] GO:0008406 |
gonad development
|
AKR1C3, BCL2, CYP19A1, ESR1, INSR |
2.28338 |
[BP] GO:0044242 |
None
|
AKR1B10, AKR1C3, CYP1B1, FABP3, FABP4, GBA2 |
2.26489 |
[BP] GO:1903963 |
None
|
DRD2, DRD3, DRD4 |
2.24527 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.24527 |
[BP] GO:0050482 |
None
|
DRD2, DRD3, DRD4 |
2.24527 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.24527 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, EGFR, IGF1R, INSR, MMP2, PTGS2, SRC |
2.24491 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.24491 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD2, EGFR, PTGS2 |
2.24491 |
[BP] GO:0050679 |
None
|
AR, EGFR, F3, KDR, MMP12, TEK |
2.24491 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CXCL8, CYP1B1, F3, KDR, PTGS2, TEK |
2.24491 |
[BP] GO:0035295 |
tube development
|
AKR1B1, AR, CXCL8, CYP1A1, EGFR, SMAD3 |
2.24491 |
[BP] GO:0031327 |
None
|
ADRA2A, AKR1C3, APEX1, AR, AURKB, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR3C1, PPARA, RORC, SMAD3, SRC |
2.24031 |
[BP] GO:0040007 |
None
|
APP, AR, BCL2, CYP19A1, ESR1, SMAD3, SRC, TNKS2 |
2.23244 |
[BP] GO:0010468 |
regulation of gene expression
|
ADORA3, APEX1, APP, AR, AURKB, BCL2, CA9, CDK6, CSNK2A1, CYP1A2, CYP1B1, DRD2, DRD3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, HSPA1A, INSR, KDR, MET, MIF, MMP12, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, SMAD3, SRC, TNKS, TOP2A, XDH |
2.22188 |
[BP] GO:0071384 |
None
|
AKR1C3, EGFR, FLT3, NR3C1 |
2.22188 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.22188 |
[BP] GO:0019229 |
None
|
ADRA2A, ADRA2C, EGFR, PTGS2 |
2.22188 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA2C, AKR1C3, AR, AXL, BCL2, DRD2, DRD3, ESR2, PGR, PTGS2, SLC6A2, TEK |
2.21585 |
[BP] GO:0030154 |
cell differentiation
|
AKR1C3, ALPL, AR, AXL, BCL2, CBR1, CDK6, CYP1A1, ESR1, FABP4, FLT3, FUT7, GLO1, KDR, MMP2, MMP9, PTGS2, RORC, SMAD3, TOP2A |
2.21473 |
[BP] GO:0045927 |
positive regulation of growth
|
BCL2, CSNK2A1, DRD2, EGFR, INSR, PIM1, SLC6A3 |
2.20473 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, MIF, MMP12, SRC |
2.20473 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, ALOX15, AXL, CXCL8, EPHX2, MIF, PTGS1, PTGS2 |
2.20333 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.20297 |
[BP] GO:0071875 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.20297 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.20297 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.20098 |
[BP] GO:0031279 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.20098 |
[BP] GO:0009890 |
None
|
ADRA2A, AKR1C3, APEX1, AR, AURKB, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR3C1, PPARA, RORC, SMAD3, SRC |
2.18455 |
[BP] GO:0007610 |
None
|
APP, BCL2, DRD2, DRD3, DRD4, EGFR, INSR, PPARA, PTGS2, SLC6A3 |
2.18292 |
[BP] GO:0044283 |
None
|
AKR1B1, AKR1C3, ALOX15, ALOX5, CYP19A1, CYP1A1, MIF, PTGS1, PTGS2 |
2.1807 |
[BP] GO:0034762 |
None
|
ADRA2A, APP, BCL2, CA2, DRD2, DRD3, DRD4, GPR35, MMP9 |
2.1807 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.1789 |
[BP] GO:0051339 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.1784 |
[BP] GO:0060341 |
regulation of cellular localization
|
ADRA2A, APP, AR, BCL2, CSNK2A1, DRD2, DRD3, DRD4, EGFR, PTGS2, PTPN1, SMAD3, SRC |
2.15982 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD2, DRD3, DRD4 |
2.1586 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, AKR1C3, ALPL, AXL, BCL2, CDK6, CXCL8, CYP1A1, CYP1A2, DRD3, EGFR, HSD11B2, MMP12, PTGS2, SMAD3, SRC, TYR |
2.1586 |
[BP] GO:0045932 |
None
|
ADORA1, ADRA2C, PTGS2 |
2.1586 |
[BP] GO:0055065 |
metal ion homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, GPR35, SMAD3 |
2.15815 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, MMP9, RORC |
2.15815 |
[BP] GO:0046888 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD2 |
2.15815 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
2.15815 |
[BP] GO:0043086 |
negative regulation of catalytic activity
|
ADRA2A, APP, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, FABP4, IGF1R, MMP9, PTGS2, PTPN1, SRC |
2.15815 |
[BP] GO:1903531 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD2, DRD3, DRD4 |
2.15815 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.15815 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.15815 |
[BP] GO:0035624 |
None
|
ADRA2A, ADRA2C |
2.15815 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1 |
2.15815 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.15815 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.15815 |
[BP] GO:0014060 |
None
|
ADRA2A, ADRA2C |
2.15815 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.15815 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, ADRA2A, BCL2, EGFR, MET, PPARA, SMAD3 |
2.14858 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD2, PTGS2 |
2.14384 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.14384 |
[BP] GO:0008150 |
biological_process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH |
2.14313 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CYP1A1, EGFR, ESR1, PGR, PTGS2, SRC |
2.14185 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.12818 |
[BP] GO:0032309 |
None
|
DRD2, DRD3, DRD4 |
2.12818 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.12818 |
[BP] GO:0001975 |
None
|
DRD2, DRD3, DRD4 |
2.12818 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.12564 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA2A, ADRA2C, PTGS2 |
2.12564 |
[BP] GO:0006081 |
None
|
AKR1B10, AKR1C3, CYP1B1, GLO1 |
2.12564 |
[BP] GO:0010959 |
None
|
ADORA1, ADRA2A, BCL2, DRD2, DRD3, DRD4, GPR35, PTGS2 |
2.12146 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.12146 |
[BP] GO:0040011 |
locomotion
|
AXL, CXCL8, CYP1B1, DRD2, EGFR, FUT7, KDR, MET, MIF, MMP1, MMP12, MMP9, SRC, TEK |
2.10646 |
[BP] GO:0010675 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.10599 |
[BP] GO:1901361 |
None
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP2A6, EPHX2, HSPA1A, SLC6A3, XDH |
2.10395 |
[BP] GO:0000122 |
None
|
AR, AURKB, DRD3, ESR1, ESR2, ESRRA, HSPA1A, MMP12, NR3C1, PPARA, RORC, SMAD3 |
2.08779 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.08559 |
[BP] GO:0019725 |
cellular homeostasis
|
APEX1, APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
2.07963 |
[BP] GO:0050890 |
None
|
ADORA1, APP, DRD2, DRD3, EGFR, INSR, PTGS2 |
2.07589 |
[BP] GO:0007584 |
response to nutrient
|
AKR1C3, ALPL, CYP1A1, EGFR, PTGS2, TYR |
2.06495 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, PTGS2 |
2.06174 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.05899 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.05899 |
[BP] GO:0048870 |
cell motility
|
AXL, CXCL8, CYP1B1, DRD2, EGFR, FUT7, KDR, MIF, MMP1, MMP12, MMP9, SRC, TEK |
2.0326 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CXCL8, CYP1A1, CYP1A2, PTGS2, SRC |
2.03239 |
[BP] GO:0010760 |
negative regulation of macrophage chemotaxis
|
CYP19A1, MIF |
2.01792 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.01792 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.01792 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.01792 |
[BP] GO:0032415 |
None
|
DRD3, DRD4 |
2.01792 |
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A3 |
2.01792 |
[BP] GO:0021984 |
None
|
DRD2, SLC6A3 |
2.01792 |
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A3 |
2.01792 |
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A3 |
2.01792 |
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A3 |
2.01792 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.01792 |
[BP] GO:0016115 |
None
|
AKR1B10, AKR1C3 |
2.01792 |
[BP] GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway
|
ADRA2A, CXCL8, DRD2, DRD3, MET |
2.01483 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
2.01483 |
[BP] GO:0010556 |
regulation of macromolecule biosynthetic process
|
ADORA3, APEX1, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, SMAD3, SRC, TNKS, TNKS2, TOP2A |
2.01434 |
[BP] GO:0071715 |
None
|
DRD2, DRD3, DRD4 |
2.01434 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.01434 |
[BP] GO:1901571 |
None
|
DRD2, DRD3, DRD4 |
2.01434 |
[BP] GO:0050921 |
positive regulation of chemotaxis
|
CXCL8, F3, KDR, MET, SMAD3 |
2.00349 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AR, AXL, BCL2, CA2, CA9, CYP1B1, DRD2, EGFR, ESR1, INSR, MET, MMP2, SMAD3, SRC, TEK |
2.0029 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA2C, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APEX1, APP, AR, AURKB, BCL2, CA1, CA2, CA4, CA7, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MIF, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
3.84236 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, ALOX5, ALPL, APP, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, EGFR, EPHX1, ESR1, F3, FLT3, FUT7, GBA2, GLO1, GPR35, HSD11B1, HSD11B2, HSD17B2, IGF1R, INSR, KDR, MET, MMP2, NR3C2, PGR, PIM1, PTGS1, PTGS2, PTPN1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TYR |
3.7579 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, EPHX1, GBA2, HSD11B1, HSD11B2, HSD17B2, NR3C2, PTGS1, PTGS2 |
3.52005 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, EPHX1, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, NR3C2, PTGS1, PTGS2, PTPN1 |
3.43709 |
[CC] GO:0045121 |
membrane raft
|
APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A3, SRC, TEK |
3.28369 |
[CC] GO:0098857 |
membrane microdomain
|
APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A3, SRC, TEK |
3.26373 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AXL, CA4, DRD2, DRD3, DRD4, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A3, TEK |
3.243 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, ADRA2A, CA2, CA4, CA9, EGFR, TEK |
2.89697 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, F3, FLT3, GBA2, GLO1, GPR35, IGF1R, INSR, KDR, MET, MMP2, PIM1, PTPN1, SLC6A2, SLC6A3, SMAD3, SRC, TEK |
2.77558 |
[CC] GO:0098589 |
membrane region
|
APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A3, SRC, TEK |
2.74546 |
[CC] GO:0009986 |
cell surface
|
ACHE, APP, AXL, CA4, EGFR, F3, MET, MIF, SLC6A2, SLC6A3, TEK |
2.73076 |
[CC] GO:0044464 |
cell part
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH |
2.70585 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AXL, DRD2, DRD3, DRD4, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A3, TEK |
2.55856 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APP, AXL, CA2, CA4, CA9, DRD2, DRD3, DRD4, DUSP3, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PTGS2, SLC6A2, SLC6A3, SRC, TEK |
2.52476 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, ESR1, F3, FLT3, FUT7, GBA2, GPR35, HSD11B1, HSD11B2, HSD17B2, IGF1R, INSR, KDR, MET, NR3C2, PTGS1, PTGS2, PTPN1, SLC6A2, SLC6A3, SRC, TEK, TYR |
2.49805 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, ADRA2C, AKR1B1, AKR1B10, AKR1C3, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA2, CA4, CBR1, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.20081 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.01792 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPN1, RORC, SMAD3, TNKS, TYR, XDH |
18.4362 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH |
14.4588 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, EPHX1, EPHX2, F3, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGS1, PTGS2, PTPN1, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH |
11.768 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, EPHX2, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SMAD3, TNKS, TNKS2, TOP2A, TYR, XDH |
10.8853 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
10.0267 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARA, PTPN1, RORC, SMAD3, TNKS |
9.95097 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, NR3C1, NR3C2, PGR, RORC |
9.90611 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.87078 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PTGS1, PTGS2, TYR, XDH |
9.17979 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SMAD3, TNKS, TNKS2, TOP2A, TYR, XDH |
8.85442 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AR, AXL, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TEK |
7.76213 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PGR, PPARA, RORC |
7.76014 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PGR, PPARA, RORC |
7.76014 |
[MF] GO:1901338 |
None
|
ADRA2A, ADRA2C, DRD2, DRD3, DRD4, SLC6A3 |
7.12919 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AR, AXL, CDK6, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TEK |
7.10421 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.00802 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, AOX1, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
6.83415 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AR, AXL, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TEK |
6.76074 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AR, AXL, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, SMAD3, TEK |
6.54128 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.48241 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.43653 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, TYR |
6.34984 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.2758 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
6.23383 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.01641 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, SRC |
5.92754 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, DRD2, DRD3, DRD4, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SLC6A3, SRC, TEK, TOP2A |
5.89324 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, NR3C1, NR3C2, PGR, PPARA, RORC |
5.7931 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
5.72675 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, SRC |
5.68218 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, ADRA2C, AOX1, APP, BCL2, CSNK2A1, DRD2, DRD4, EGFR, EPHX2, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MIF, MMP9, PGR, PTGS2, SMAD3, TOP2A, TYR, XDH |
5.20359 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.14592 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, APP, AR, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, HSPA1A, MET, MIF, NR3C1, PGR, PPARA, PTGS2, PTPN1, SLC6A3, SMAD3, SRC, TEK, TNKS2, TOP2A |
5.0564 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.04707 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A3, SMAD3, SRC |
4.95563 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A3, SMAD3, SRC |
4.90856 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, HSD17B1, IGF1R, INSR, NR3C1 |
4.85603 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.83002 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.79518 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
4.7406 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.6836 |
[MF] GO:0035240 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
4.54351 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B2, HSD17B1, PTGS1, PTGS2, SRC, XDH |
4.51145 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, ADRA2C, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
4.11682 |
[MF] GO:0005102 |
receptor binding
|
ADORA1, ADRA2A, ADRA2C, APP, AR, CXCL8, DRD2, DRD3, EGFR, EPHX2, ESR1, ESR2, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, PTPN1, SLC6A3, SMAD3, SRC |
3.92626 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.87082 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, AOX1, XDH |
3.85106 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
3.80787 |
[MF] GO:0051379 |
None
|
ADRA2A, ADRA2C, DRD4 |
3.4492 |
[MF] GO:0001591 |
None
|
DRD2, DRD3, DRD4 |
3.4492 |
[MF] GO:0016803 |
ether hydrolase activity
|
ALOX15, EPHX1, EPHX2 |
3.30606 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.30606 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PPARA, PTPN1, SLC6A3, SMAD3 |
3.18461 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.09475 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.00723 |
[MF] GO:0004952 |
None
|
DRD2, DRD3, DRD4 |
2.95357 |
[MF] GO:0016801 |
None
|
ALOX15, EPHX1, EPHX2 |
2.95357 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.94851 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
2.94851 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.94851 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.94851 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.94851 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD2, DRD3, DRD4, SLC6A3 |
2.9351 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.75009 |
[MF] GO:0004935 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.63095 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, DRD2, DRD3, DRD4, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
2.62798 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, DRD2, DRD3, DRD4, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
2.62798 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA2A, ADRA2C, AOX1, AR, AXL, BCL2, DRD2, EGFR, EPHX2, FLT3, PTGS2, SMAD3, TOP2A, TYR, XDH |
2.60827 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.56487 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.56487 |
[MF] GO:0004938 |
None
|
ADRA2A, ADRA2C |
2.56487 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A3 |
2.56487 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, ADRA2C, AOX1, BCL2, DRD2, EPHX2, FLT3, PTGS2, SMAD3, TOP2A, TYR, XDH |
2.53352 |
[MF] GO:0000978 |
None
|
AR, ESR1, ESR2, ESRRA, NR3C1, PGR, PPARA, RORC, SMAD3 |
2.4598 |
[MF] GO:0046982 |
protein heterodimerization activity
|
ADORA1, ADRA2A, ADRA2C, AXL, BCL2, DRD2, EGFR, SMAD3, TOP2A, TYR |
2.4141 |
[MF] GO:0000987 |
None
|
AR, ESR1, ESR2, ESRRA, NR3C1, PGR, PPARA, RORC, SMAD3 |
2.34218 |
[MF] GO:0031072 |
heat shock protein binding
|
ADORA1, CSNK2A1, HSPA1A, KDR, NR3C1 |
2.32862 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.32862 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.32862 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.32862 |
[MF] GO:0003674 |
molecular_function
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH |
2.31396 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.28338 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
2.1586 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.15815 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.15815 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.15815 |
[MF] GO:0051380 |
None
|
ADRA2A, DRD4 |
2.15815 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.15088 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, EGFR, MET, PTPN1, SLC6A3 |
2.14497 |
[MF] GO:0019900 |
None
|
ADRA2A, AURKB, CDC25B, DUSP3, EGFR, ESR1, NR3C1, PTPN1, SMAD3, SRC, TOP2A |
2.13628 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.12818 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, PTGS2 |
2.12818 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, PTGS2 |
2.08559 |
[MF] GO:0051721 |
None
|
BCL2, PTPN1, SLC6A3 |
2.04229 |
[MF] GO:0043565 |
None
|
APEX1, AR, BCL2, ESR1, ESR2, ESRRA, ESRRB, MMP12, NR3C1, NR3C2, PGR, PPARA, RORC, SMAD3 |
2.01792 |
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A3 |
2.01792 |
[MF] GO:0004936 |
None
|
ADRA2A, ADRA2C |
2.01792 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.01792 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.01792 |
[MF] GO:0047035 |
testosterone dehydrogenase (NAD+) activity
|
AKR1C3, HSD17B2 |
2.01792 |
[MF] GO:0004301 |
None
|
EPHX1, EPHX2 |
2.01792 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.01434 |
[MF] GO:0019901 |
None
|
ADRA2A, CDC25B, DUSP3, EGFR, ESR1, NR3C1, PTPN1, SMAD3, SRC, TOP2A |
2.00483 |